Climb Bio, Inc. (CLYM) — Operating Income
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$67.88M | +17.2% |
| 2024 | -$82.02M | -103.6% |
| 2023 | -$40.27M | +10.8% |
| 2022 | -$45.13M | -26.5% |
| 2021 | -$35.67M | -70.5% |
| 2020 | -$20.93M | — |
| Fiscal Year | Operating Income | Change YoY |
|---|---|---|
| 2025 | -$67.88M | +17.2% |
| 2024 | -$82.02M | -103.6% |
| 2023 | -$40.27M | +10.8% |
| 2022 | -$45.13M | -26.5% |
| 2021 | -$35.67M | -70.5% |
| 2020 | -$20.93M | — |